Physician profile
Darryl A Auston
NPI 1962637983
$191,744.13
in general payments reported to CMS, 2019-2025
15 companies · $56K in 2025
The $56K reported for 2025 was more than what 92% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,353 · 2020: $1,171 · 2021: $6,956 · 2022: $61K · 2023: $38K · 2024: $24K · 2025: $56K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $54K · Consulting Fee: $47K · Travel and Lodging: $13K · Food and Beverage: $3,436 · Education: $36.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,000.00 |
| Consulting Fee | $47,255.00 |
| Travel and Lodging | $13,179.09 |
| Food and Beverage | $3,435.88 |
| Education | $36.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $87,231.73 | 2019-2025 | Evos, Trigen Intertan, Evos Mini |
| Globus Medical, INC. | $45,267.24 | 2022-2023 | Distal Femur Plate System, Ankle Fracture System, Proximal Femur |
| Si-Bone, INC. | $36,261.09 | 2024-2025 | |
| Medartis INC. | $11,414.99 | 2022-2025 | Aptus |
| Xenco Medical LLC | $6,600.00 | 2025 | Flowable Orthobiologics, Regenerative Tissue Membrane |
| Nextremity Solutions INC. | $2,180.00 | 2021 | |
| Medical Device Business Services, INC. | $900.00 | 2021 | |
| Acumed LLC | $835.01 | 2019 | |
| Biotissue Holdings INC. | $671.76 | 2022-2024 | |
| Depuy Synthes Sales INC. | $143.26 | 2020-2023 | Na, Tfn-Advance |
| Stryker Corporation | $90.60 | 2021-2023 | Bio4 |
| Zimmer Biomet Holdings, INC. | $61.57 | 2021 | |
| Bioventus LLC | $44.01 | 2025 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $21.97 | 2019 | |
| Kerecis Limited | $20.90 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darryl Auston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.